Resveratrol Inhibits Cdk5 Activity through Regulation of p35 Expression

Resveratrol-Induced Apoptosis Is Mediated by Early Growth Response-1, Kruppel-Like Factor 4, and Activating Transcription Factor 3

(2011) N. C. Whitlock et al.   Cancer Prevention Research

ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease

(2010) Pamela Maher et al.   HUMAN MOLECULAR GENETICS

Resveratrol differentially modulates inflammatory responses of microglia and astrocytes

(2010) Xiaofeng Lu et al.   Journal of Neuroinflammation

Neuroprotective potential of combination of resveratrol and 4-amino 1,8 naphthalimide in experimental diabetic neuropathy: Focus on functional, sensorimotor and biochemical changes

(2009) Shyam S. Sharma et al.   FREE RADICAL RESEARCH

Disruption of Cdk5-Associated Phosphorylation of Residue Threonine-161 of the  -Opioid Receptor: Impaired Receptor Function and Attenuated Morphine Antinociceptive Tolerance

(2009) W.-Y. Xie et al.   JOURNAL OF NEUROSCIENCE

Resveratrol inhibits EMMPRIN expression via P38 and ERK1/2 pathways in PMA-induced THP-1 cells

(2008) Zhouqing Huang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Resveratrol: A Natural Compound with Pharmacological Potential in Neurodegenerative Diseases

(2008) Héctor I. Rocha-González et al.   CNS Neuroscience & Therapeutics

Tumor Necrosis Factor-α Regulates Cyclin-dependent Kinase 5 Activity during Pain Signaling through Transcriptional Activation of p35

(2008) Elias Utreras et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Antinociceptive effect of resveratrol in carrageenan-evoked hyperalgesia in rats: Prolonged effect related to COX-2 expression impairment

(2008) Thi Aurore Pham-Marcou et al.   PAIN

Analgesic Resveratrol?

(2007) Aldo Bertelli et al.   ANTIOXIDANTS & REDOX SIGNALING